Abstract

Single-stranded DNA molecules containing a 15-nucleotide consensus sequence have been reported to inhibit thrombin activity. The mechanism of the inhibition was studied using a consensus 15-mer oligonucleotide and two recombinant mutant thrombins: the anion-binding exosite mutant thrombin R70E, and thrombin K154A, in which the mutation was located in a surface loop outside of the exosite. The consensus 15-mer oligonucleotide inhibited both fibrinogen-clotting and platelet-activation activities of plasma-derived thrombin, recombinant wild type thrombin, and mutant thrombin K154A in a sequence-specific and dose-dependent manner, whereas it did not inhibit either activity of mutant thrombin R70E. The 15-mer oligonucleotide also inhibited thrombomodulin-dependent protein C activation by plasma-derived thrombin. In competition equilibrium binding experiments, binding of 125I-labeled diisopropyl phosphoryl-thrombin to thrombomodulin was completely inhibited by the consensus 15-mer oligonucleotide with a Kd value of 2.68 +/- 0.16 nM. These results suggest that Arg-70 in the anion-binding exosite of thrombin is a key determinant for interaction with specific single-stranded DNA molecules, and that binding of single-stranded DNA molecules to the exosite prevents the interaction of thrombin with fibrinogen, the platelet thrombin receptor, and thrombomodulin.

Highlights

  • One of the unique features of thrombin structure is the presence of many basic amino acid residues within surface loops (12), especially ina region called the anion-binding exosite (1).These positively charged residues contribute significantly to the specificity of thrombin activity

  • To determine whether the DNA molecules bind to the thrombin anion-binding exosite, the effects were examined of the consensus 15-mer oligonucleotide on wild type thrombin and on mutant thrombinswith single amino acid substitutions in or near the anion-binding exosite

  • The results suggest that the single-stranded DNA binding site is located in the thrombin anion-binding exosite and overlaps with the binding sites for fibrinogen, the platelet thrombin receptor, and thrombomodulin

Read more

Summary

1To whom correspondence should be addressed Howard Hughes

Materials-Recombinant human thrombomodulin was expressed on the surfaceof stably transfected CV-l(l8A) or CV-l(TMncc)ells, as described previously (24, 27). Human thrombin was from Haematologic Technologies Inc., Essex Junction, VT. Recombinant human protein C was kindlyprovided by Dr S. T h e sequences of two oligonucleotides used in this study were identical to those described by Bock et al (11): consensus 15-mer (C15-mer),’ GGTTGGTGTGGTTGG; scrambled 15-mer (S15-mer), GGTGGTGGTTGTGGT. ’ The abbreviations used are: C15-mer, consensus 15-meroligonucleotide; cC15-mer, oligonucleotide with sequence complementary to the C15-mer; S15-mer, scrambled 15-meroligonucleotide; DIP, diisopropyl phosphoryl; HPLC, high-performancleiquid chromatography. Chromatography methodsa, s describedpreviously (17)P. urified plasma and recombinant prothrombinswere activated to the thrombin form by E. carinatusvenom (1pg of venom/lO pg ofprothrombin)

RESULTS
Thrombin Thrombin
Thrombh Thornbln
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call